Document is current
Any future updates will be listed below
-
Authors
Khazaei, Omid
Laffey, Caoimhe M.
Sheerin, Rionach
McNicholas, Bairbre A.
Pham, Tài
Heunks, Leo
Bellani, Giacomo
Brochard, Laurent
Simpkin, Andrew J.
Laffey, John G.
,
-
Funding
Funding for this research was provided by:
Health Research Board
European Respiratory Society
European Society of Intensive Care Medicine
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 25 February 2025
First Online: 13 March 2025
Declarations
:
: All participating ICUs obtained ethics committee approval and obtained either patient consent or ethics committee waiver of consent in the WEAN SAFE study. The WEAN SAFE study was registered at Clinicaltrials.gov, number NCT03255109.
: Not Applicable.
: CL, RS, OK, BM, and AS have no conflicts of interest to report. GB reports a grant from Drager to his institution, consulting fees from Flowmeter, payments/honoraria from Drager and Getinge, and stock options in Dico technologies. LH reports funding from the European Respiratory Society to his institution support the study; grants from Liberate Medical and InflaRx to his institution, honoraria from Getinge and American Thoracic Society and reimbursement from European Respiratory Society. LB reports grants from Medtronic, Drager and Stimity to his institution, honoraria and equipment received from Fisher Paykel. JGL reports grants from Science Foundation Ireland and Health Research Board Ireland to his institution, and consulting fees from Cellenkos.
